O nce clinical suspicion has been established for primary biliary cholangitis (PBC), the " serologic hallmark " of the ...

Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 people have PSC.

Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 people have PSC.

Primary Sclerosing Cholangitis (PSC): Diagnosing and Living With This Liver Condition. Medically reviewed by Saurabh Sethi, M.D., MPH — Written by Ashley Marcin — Updated on June 30, 2025.

Sclerosing cholangitis and primary biliary cirrhosis, which is now called primary biliary cholangitis (PBC), are chronic cholestatic liver diseases, but they differ in their causes, affected bile ...

Primary Sclerosing Cholangitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as .

Primary sclerosing cholangitis (PSC) is an autoimmune injury in which infiltrating T lymphocytes are implicated in bile duct destruction through an as yet, unknown mechanism. In July Gut, Bo and ...

Levy. C. et al. Elafibranor for primary sclerosing cholangitis: The ELMWOOD phase II randomised controlled trial. European Association for the Study of the Liver (EASL) congress, 2025.

Primary biliary cholangitis is a disease affecting the bile made by your liver. Here’s what to know about the causes, symptoms, treatment, and outlook.

The global primary sclerosing cholangitis (PSC) market is on an impressive growth trajectory, with forecasts estimating a market valuation of USD 314.26 million by 2033. This robust expansion is ...

—New Patents Covering Use of Nebokitug for the Treatment of Liver Diseases including Primary Sclerosing Cholangitis Issued in China and Russia Providing Coverage Up To 2041— —Further Expands ...